Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds

by Amin, N., Bachert, C., Chuang, C.-C, Daizadeh, N., Duverger, N., Fan, C., Fokkens, W.J, Guillemin, I., Hellings, P.W, Kamat, S., Khan, A.H, Lee, S.E, Mannent, L.P
Published 2022

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized pl...

by Amin, N., Bachert, C., Canonica, G.W, Daizadeh, N., Han, J., Laidlaw, T.M, Laws, E., Li, Y., Mannent, L.P, Maspero, J.F, Mullol, J., Ortiz, B., Picado, C., Ruddy, M.
Published 2022

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

by Barro, C., Benkert, P., Chung, L., Daizadeh, N., Godin, J., Havari, E., Jacobs, A., Kaiser, C., Kappos, L., Kuhle, J., Leppert, D., Maceski, A., Michalak, Z., Mitchell, C.P, Rӧsch, N., Samad, T.A, Shankara, S., Sormani, M.P
Published 2022